Schonfeld Strategic Advisors LLC Syros Pharmaceuticals, Inc. Transaction History

Schonfeld Strategic Advisors LLC

  • $14.6 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$0.69 - $1.21 $10,355 - $18,159
15,008 Added 99.39%
30,108 $28,000
Q1 2022

May 16, 2022
BUY
$1.02 - $3.8 $15,402 - $57,380
15,100 New
15,100 $18,000
Q1 2021

May 17, 2021
SELL
$7.19 - $14.95 $88,437 - $183,885
-12,300 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$6.66 - $14.66 $81,918 - $180,318
12,300 New
12,300 $134,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email